Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Taku Miyashita is active.

Publication


Featured researches published by Taku Miyashita.


Journal of Gastroenterology | 1994

A case of appendiceal cancer metastatic to the stomach with pseudomyxoma peritonei

Taku Miyashita; Etsuo Hoshino; Tetsuo Imamura; Kouta Okinaga; Ieo Akaoka; Hideo Miyashita

Appendiceal cancer associated with pseudomyxoma peritonei is a low grade malignancy and its extraperitoneal metastasis is extremely rare. We report a case of gastric metastasis of this tumor in a 76-year-old man. Two metastatic gastric tumors, which appeared after a 1-year interval, were successfully resected endoscopically. The patient was well for more than 3 years after the onset of the disease. To our knowledge, gastric metastasis from appendiceal cancer with pseudomyxoma peritonei has not been previously reported.


Chemotherapy | 1994

Comparative study of the effects of cefodizime and HBW 538 in potentiating the production of reactive oxygen species by human polymorphonuclear leukocytes.

Yasuo Ono; Otohiko Kunii; I. Ohyatsu; Y. Tokumura; Taku Miyashita; Masumi Aoki; Hajime Sugiyama; Hajime Nishiya; Hideo Miyashita; E. Goldstein

The immunomodulatory activity of cefodizime (CDZM), an aminothiazolylcephalosporin, was compared to that of HBW 538, a derivative of the CDZM side chain at position 3 (the mercaptothiazolyl group) in respect to the production of reactive oxygen species (ROS) by human whole blood and polymorphonuclear leukocytes (PMN) in vitro. Ten-fold diluted whole blood and PMN from healthy individuals were incubated with CDZM or HBW 538 alone at the concentrations of 1, 10, or 100 micrograms/ml, or CDZM or HBW 538 at 100 micrograms/ml in combination with tumor necrosis factor-alpha (TNF-alpha) at 100 U/ml or lipopolysaccharide (LPS) at 1 microgram/ml. The production of ROS was measured by a chemiluminescence (CL) assay in which luminol was added to a mixture and after which the PMN or whole blood were stimulated with nonopsonized zymosan or phorbol myristate acetate. The following results were obtained: (1) The CL responses of whole blood and PMN were slightly but not significantly enhanced by CDZM at 100 micrograms/ml, whereas both CL responses were significantly enhanced by exposure to HBW 538 at 10 and 100 micrograms/ml. (2) The enhanced PMN CL response which followed priming with TNF-alpha or LPS was not augmented by CDZM but was significantly augmented by HBW 538. These results indicate that the ability of the HBW 538 molecule to enhance the production of ROS by stimulated PMN and to act agonistically with TNF-alpha or LPS is abrogated when HBW 538 is part of the CDZM molecule.(ABSTRACT TRUNCATED AT 250 WORDS)


Digestive Diseases and Sciences | 1999

Case Report: Acidic Glycosaminoglycans of Abdominal Mucin in a Case of Pseudomyxoma Peritonei Caused by Appendiceal Cancer

Taku Miyashita; Katsumi Murata; Etsuo Hoshino; Hajime Nishiya; Yasuo Ono; Ieo Akaoka

Although the use of intraperitoneal mucolytic agents is useful in the management of pseudomyxoma peritonei, effective removal of mucin is difficult even by repeated mucolysis in cases with massive ascites. To establish mucolytic therapy as a further effective procedure, biochemical analysis of mucin is required in greater detail. We reported here a case of pseudomyxoma peritonei caused by primary appendiceal cancer with biochemical analysis of mucin. The abdominal cavity in this case was filled with massive mucinous ascites. Although the mucolytic therapy was performed repeatedly, it was not effective in preventing mechanical ileus which was followed by surgical exclusion. Biochemical study of mucin showed that the mucin contained a small amount of hyaluronic acid, as characterized by electrophoretic study. These data led us to the hypothesis that the hyaluronic acid component plays a role in the pathogenesis of the replacement of mucin in the abdominal cavity.


Journal of Infection and Chemotherapy | 2002

Destructive pulmonary embolism in a patient with community-acquired staphylococcal bacteremia

Taku Miyashita; Yuko Shimamoto; Hajime Nishiya; Yoji Koshibu; Hajime Sugiyama; Yasuo Ono; Takayoshi Satoh; Hitomi Haraoka; Junichi Nakano; Ken Ohta; Tomohide Sato; Naoko Morinaga; Masatoshi Noda


Internal Medicine | 1994

Primary Retroperitoneal Synovial Sarcoma

Taku Miyashita; Tetsuo Imamura; Yasuro Ishikawa; Kouta Okinaga; Otohiko Kunii; Hideo Miyashita


Journal of Infection and Chemotherapy | 2000

Bacteremic Moraxella catarrhalis pneumonia in a patient with immunoglobulin deficiency.

Hajime Sugiyama; Eri Ogata; Yuko Shimamoto; Youji Koshibu; Kaoru Matsumoto; Keiko Murai; Taku Miyashita; Yasuo Ono; Hajime Nishiya; Otohiko Kunii; Tomohide Sato


The Journal of the Japanese Association for Infectious Diseases | 1994

Anti-endotoxic Activity of Murine Monoclonal Antibody (E5) Assessed by Inhibition of Priming of Human Phagocytes by Endotoxin

Yasuo Ono; Yasuaki Tokumura; Taku Miyashita; Kunio Kobayashi


The Journal of the Japanese Association for Infectious Diseases | 1998

Immunoglobulin Production by Human Peripheral B Cells against Staphylococcus aureus

Taku Miyashita; Junko Kato; Yasuo Ono; Keiko Kawamata; Tadashi Ito; Hajime Sugiyama; Kaoru Matsumoto; Yuko Shmamoto; Hajime Nishiya; Tomohide Sato


The Journal of the Japanese Association for Infectious Diseases | 1997

Primary HIV-1 Infectionの1例

Hajime Sugiyama; Keiko Kawamata; Junko Katoh; Taku Miyashita; Tadashi Itoh; Isao Ohyatsu; Masumi Aoki; Yasuo Ono; Hajime Nishiya; Tomohide Satoh


The Journal of the Japanese Association for Infectious Diseases | 1995

A Case Report of Toxic Shock-like Syndrome due to Group A Streptococcal Infection in an Alcoholic

Yasuo Ono; Megumi M; Hajime Sugiyama; Yasuaki Tokumura; Isao Ohyatsu; Taku Miyashita; Junko Kato; Hajime Nishiya; Hideo Miyashita

Collaboration


Dive into the Taku Miyashita's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge